Insulet Corp (PODD) News & Events

$141.900

-0.738 (-0.52%)At close

PODD News

5.010-12Newsfilter

Insulet Launches Omnipod Discover Data Platform for Diabetes Management

1.009-18Newsfilter

Insulet Corporation to Present at Healthcare Forum

7.509-01CNBC

Insulet Faces Execution Issues Masking Strong Fundamentals

7.008-28PRnewswire

Reminder for Insulet Corporation Securities Class Action

5.008-24Fool

Insulet CEO's Stock Purchase Signals Confidence

5.008-24NASDAQ.COM

Insulet CEO's Stock Purchase Signals Bullish Outlook

7.008-20PRnewswire

Key Disclosure Events for Insulet Corporation Shareholders

7.008-20PRnewswire

Insulet Corporation Faces Class Action Lawsuit

7.008-19PRnewswire

Insulet's Manufacturing Quality Under Scrutiny, Shares Plunge $90

7.008-18Newsfilter

ARS Pharmaceuticals and Others Under Shareholder Investigation

Show More News

PODD Events

10/12 07:30

Insulet Announces Full Market Release of Omnipod Discover

Insulet announced the U.S. full market release of Omnipod Discover. "The future of diabetes care is not just about generating more data, it's about making that data meaningful," said Dr. Trang Ly, MBBS, FRACP, PhD, Senior Vice President and Chief Medical Officer at Insulet. "Omnipod Discover simplifies data review for Omnipod 5 users and their healthcare providers so they spend less time gathering information and more time collaborating on diabetes management."

8/5 12:30

Insulet Shares Drop 20.7% to $132.29

Insulet is down -20.7%, or -$34.53 to $132.29.

8/5 10:30

Insulet Shares Drop 19.7% to $134.03

Insulet is down -19.7%, or -$32.80 to $134.03.

Show More Events

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.